CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma

CONCLUSION: We report that increased CDK1 promotes tumor progression and identified it as a potential prognostic marker and therapeutic target of EMCA.PMID:38456590 | DOI:10.3802/jgo.2024.35.e68
Source: Journal of Gynecologic Oncology - Category: OBGYN Authors: Source Type: research